Swedbank Ab Merck & Co., Inc. Transaction History

Swedbank Ab

$95.2 Billion
Q3 2025

A detailed history of Swedbank Ab transactions in Merck & Co., Inc. stock. As of the latest transaction made, Swedbank Ab holds 8,344,126 shares of MRK stock, worth $775 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

8,344,126

Previous 7,874,766 5.96%

Holding current value

$775 Million

Previous $623 Million 12.35%

% of portfolio

0.74%

Previous 0.72%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$77.6 - $87.37 $36.4 Million - $41 Million	469,360 Added 5.96%	8,344,126 $700 Million
Q2 2025 Jul 10, 2025	SELL	$73.47 - $87.12 $8.32 Million - $9.86 Million	-113,211 Reduced 1.42%	7,874,766 $623 Million
Q1 2025 Jun 23, 2025	BUY	$83.01 - $101.02 $27.2 Million - $33.1 Million	327,325 Added 4.27%	7,987,977 $717 Million
Q4 2024 Jan 23, 2025	BUY	$96.31 - $114.76 $738 Million - $879 Million	7,660,652 New	7,660,652 $762 Million
Q3 2024 Oct 15, 2024	BUY	$111.15 - $128.97 $233 Million - $270 Million	2,095,694 Added 38.56%	7,530,111 $855 Million

Q2 2024 Jul 18, 2024	BUY	$123.8 - $132.96 $673 Million - $723 Million	5,434,417 New	5,434,417 $673 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $622 Million - $725 Million	5,492,811 New	5,492,811 $725 Million
Q4 2023 Dec 09, 2024	BUY	$100.18 - $109.02 $61.3 Million - $66.7 Million	612,113 Added 12.74%	5,418,564 $591 Million
Q3 2023 Dec 09, 2024	BUY	$102.95 - $114.33 $22.8 Million - $25.4 Million	221,797 Added 4.84%	4,806,451 $495 Million
Q2 2023 Dec 09, 2024	SELL	$108.61 - $118.38 $58.1 Million - $63.3 Million	-534,720 Reduced 10.45%	4,584,654 $529 Million
Q1 2023 Dec 09, 2024	BUY	$102.94 - $114.86 $6.36 Million - $7.1 Million	61,810 Added 1.22%	5,119,374 $545 Million
Q4 2022 Dec 09, 2024	BUY	$87.44 - $112.11 $27.9 Million - $35.8 Million	318,921 Added 6.73%	5,057,564 $561 Million
Q3 2022 Dec 09, 2024	SELL	$84.53 - $94.96 $24.5 Million - $27.5 Million	-289,850 Reduced 5.76%	4,738,643 $408 Million
Q2 2022 Dec 09, 2024	BUY	$83.49 - $94.64 $7.6 Million - $8.62 Million	91,076 Added 1.84%	5,028,493 $458 Million
Q1 2022 Dec 09, 2024	BUY	$73.51 - $82.4 $3.79 Million - $4.25 Million	51,603 Added 1.06%	4,937,417 $405 Million
Q4 2021 Dec 09, 2024	SELL	$72.28 - $90.54 $791,827 - $991,865	-10,955 Reduced 0.22%	4,885,814 $374 Million
Q3 2021 Dec 09, 2024	BUY	$71.68 - $78.83 $6.69 Million - $7.36 Million	93,308 Added 1.94%	4,896,769 $368 Million
Q2 2021 Dec 09, 2024	BUY	$70.31 - $77.77 $18.4 Million - $20.3 Million	261,191 Added 5.75%	4,803,461 $374 Million
Q1 2021 Dec 09, 2024	BUY	$68.86 - $81.11 $313 Million - $368 Million	4,542,270 New	4,542,270 $334 Million

Others Institutions Holding MRK

# of Institutions

3,875

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Account